ClinConnect ClinConnect Logo
Search / Trial NCT06187207

Hand Acceleration Time (HAT) Assessment Before and After Creating an Arteriovenous Fistula (AVF)

Launched by HOSPITAL UNIVERSITARI DE BELLVITGE · Dec 16, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Hand Acceleration Time Arteriovenous Fistula Vascular Disease Hemodialysis Access Induced Distal Ischemia

ClinConnect Summary

This clinical trial is studying a specific test called hand acceleration time (HAT) before and after creating an arteriovenous fistula (AVF), which is a connection made between an artery and a vein for patients who need hemodialysis. The main goal is to see if changes in HAT can help predict problems that may occur in the blood flow after the AVF is created. Researchers also want to check how many patients experience issues related to this procedure, the success of the AVF after six months, and any complications that might arise during that time.

To participate in this study, you need to be an adult (18 years or older) who is a candidate for having an AVF created for hemodialysis. Both men and women can join, as long as they understand the study and agree to participate by signing a consent form. If you decide to join, you can expect to undergo HAT assessments at different points, and your health will be monitored for any issues related to the AVF. This trial is currently looking for volunteers, so it’s a great opportunity to contribute to important research that could help improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients (≥18 years of age)
  • Both sexes
  • Candidates for AVF creation for hemodialysis
  • Patients who sign the informed consent form
  • Exclusion Criteria:
  • Patients deemed unable by the investigators to understand or comply with study-related procedures
  • Patients who refuse to participate in the study

About Hospital Universitari De Bellvitge

Hospital Universitari de Bellvitge is a leading academic medical center located in L'Hospitalet de Llobregat, Spain, affiliated with the University of Barcelona. Renowned for its commitment to advanced patient care, innovative research, and education, the hospital plays a pivotal role in the development and execution of clinical trials across various therapeutic areas. With a multidisciplinary team of healthcare professionals and researchers, Hospital Universitari de Bellvitge strives to enhance medical knowledge and improve treatment outcomes through rigorous scientific inquiry and collaboration. Its state-of-the-art facilities and comprehensive patient care services make it an ideal environment for conducting high-quality clinical research.

Locations

L'hospitalet De Llobregat, Barcelona, Spain

Patients applied

0 patients applied

Trial Officials

Begoña Gonzalo, MD

Principal Investigator

Hospital Universitari de Bellvitge

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported